Walmart will launch the world's first brand of affordable insulin analogues under the ReliOn NovoLog Insulin brand. The drug was developed in collaboration with pharmaceutical company Novo Nordisk. Insulin ampoules will be available for $72.88, a FlexPen injection pen for $85.55. The brand's drugs will cost customers 58-75% less than their counterparts.
Walmart will launch the world's first brand of affordable insulin analogues under the ReliOn NovoLog Insulin brand. The drug was developed in collaboration with pharmaceutical company Novo Nordisk. Insulin ampoules will be available for $72.88, a FlexPen injection pen for $85.55. The brand's drugs will cost customers 58-75% less than their counterparts. 
corporate.walmart.com
English (US) 